Results of the phase III LITESPARK-005 clinical trial show that treatment with belzutifan versus everolimus significantly improves progression-free survival in…
kidney cancer
Presented at the 2022 annual Congress of the European Society for Medical Oncology (ESMO), results from three studies co-authored by…
